Medtronic plc (Nasdaq: MDT), a $30.1b Ireland-based producer of devices used in cardiovascular, neuroscience, surgical, and diabetes management applications, is acquiring Intersect ENT (Nasdaq: XENT), a developer of an ENT implant that releases steroids during sinus surgery to manage inflammation and a virtual surgical guidance platform. In...
Read More
The Walden Group is pleased to provide access to its Q2 2021 Strategic Healthcare M&A Report, which includes:
Financings (IPOs, SPACs, private) and M&A Deals are surging
Major M&A Deals by Sector
What the CEOs of Leading Medtechs are Saying
Key Stats on Top Healthcare M&A Q2 Deals
Key Stats on...
Read More
TopCon Corporation, a $1.2 billion Japan-based developer of eyecare devices and software solutions worldwide has purchased Italy-based ophthalmic device manufacturer VISIA Imaging S.r.l. The acquisition provides Topcon with a portfolio of imaging devices focused on the anterior segment to complement its existing posterior segment imaging...
Read More
Surmodics, Inc., a $107m maker of surface modification technologies for intravascular medical devices, has acquired Vetex Medical Ltd, an Ireland–based producer of venous clot removal products. Vetex developed ReVene, a thrombectomy catheter platform that is used to remove, in a single session, large, mixed-morphology blood clots commonly found...
Read More
Tecan Group Ltd, a $795m Switzerland-based global provider of laboratory instruments and solutions in life science research and clinical diagnostics, has acquired Paramit Corporation, a maker of electronics based medical devices and life science instruments. The deal accelerates Tecan's entry into medical devices and enhances Paramit's...
Read More